|Articles|February 1, 2016
- Pharmaceutical Executive-02-01-2016
- Volume 36
- Issue 2
Pharmaceutical Executive, February 2016 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2016 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 9 years ago
Life and Lipitor: Pfizer's Traci Medford-Rosowover 9 years ago
The Staying Power of Emerging Marketsover 9 years ago
Canada's Rx&D: Fresh Start for a New Eraover 9 years ago
Pharma dot-gov: A New Business Modelover 9 years ago
The Creative Impulse: Defending Pharma and Health DTCover 9 years ago
Securing Cipla’s Futureover 9 years ago
Country Report: South AfricaNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Most-Favored-Nation Policy: Outlook and Implications Beyond U.S.
2
Johnson and Johnson Reveals Plan to Separate Orthopaedics Business
3
Pharma Companies Shift Towards Direct-To-Consumer Sales in US Amidst Tariff and Pricing Turmoil
4
Nabla Bio Enters $1 Billion Multi-Year Research Collaboration with Takeda
5
